Clinical trial
Retinal Markers in Neuroinflammatory Diseases: a Prospective Observational Study
NCT06369766 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retinal Markers in Neuroinflammatory Diseases: a Prospective Observational Study
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 31, 2024
- Completion date
- February 28, 2029
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.